Evidence map›Paper›PMID 40137285›Full record

ArticleMarine drugs2025

Total Synthesis of the Marine Cyclic Depsipeptide Lagunamide D.

Huiru Nan, Xiong-En Long, Jianfei He, Hailiang Xing, Min-Jing Cheng, Jin-Bao Peng, Tao Ye, Jia-Lei Yan, Junyang Liu

Abstract read
In one paragraph

Article in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Huiru NanSchool of Pharmacy and Food Engineering, Wuyi University, Jiangmen 529020, China.
Xiong-En LongSchool of Pharmacy and Food Engineering, Wuyi University, Jiangmen 529020, China.
Jianfei HeSchool of Pharmacy and Food Engineering, Wuyi University, Jiangmen 529020, China.
Hailiang XingSchool of Pharmacy and Food Engineering, Wuyi University, Jiangmen 529020, China.
Min-Jing ChengCenter for Bioactive Natural Molecules and Innovative Drugs, and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.ORCID 0009-0008-0072-7433
Jin-Bao PengSchool of Pharmacy and Food Engineering, Wuyi University, Jiangmen 529020, China.
Tao YeState Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.ORCID 0000-0002-2780-9761
Jia-Lei YanSchool of Pharmacy and Food Engineering, Wuyi University, Jiangmen 529020, China.ORCID 0000-0003-3804-9507
Junyang LiuSchool of Pharmacy and Food Engineering, Wuyi University, Jiangmen 529020, China.ORCID 0000-0002-4622-5200

Funding

the Department of Education of Guangdong Province 2021ZDJS097
6 · The paper itself

Abstract

Lagunamide D is a structurally distinct 26-membered cytotoxic cyclic depsipeptide, originally isolated from a marine cyanobacterium. It exhibits potent antiproliferative activity in the low nanomolar range against A549 human lung adenocarcinoma cells and HCT116 colon cancer cells. A significant challenge associated with lagunamide D is its propensity for intramolecular acyl migration, which leads to the formation of a contracted 24-membered analog, lagunamide D'. This structural rearrangement complicates its isolation, characterization, and synthesis. In this study, the total synthesis of lagunamide D was achieved in a 14-step longest linear sequence, starting from the known intermediate

Indexed as

Antineoplastic AgentsCyanobacteriaDepsipeptidesAquatic OrganismsCell Line, TumorHCT116 CellsHumansAntineoplastic AgentsDepsipeptidesdepsipeptidelagunamide Dmarine natural productstotal synthesis

Identifiers

PMID40137285
PMCPMC11944260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.